PEG-coated lyophilized proliposomes: Preparation, characterizations and in vitro release evaluation of vitamin E

European Food Research and Technology

Volumn 232, Issue 4, 2011, Pages 647-654

  Zhao, Li Ping ^a   Xiong, Hua ^a   Peng, Hailong ^a   Wang, Qiang ^a   Han, Dan ^a   Bai, Chun Qing ^a   Liu, Yu Zhen ^a   Shi, Su Hua ^a   Deng, Bo ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Controlled release; Lyophilization; PEG; Proliposomes; Vitamin E

Indexed keywords

CONTROLLED RELEASE; LYOPHILIZATION; PEG; PROLIPOSOMES; VITAMIN E;

ENCAPSULATION; HYDROGEN; HYDROGEN BONDS; LIPOSOMES; PHOSPHOLIPIDS; POLYETHYLENE OXIDES;

POLYETHYLENE GLYCOLS;

GLYCINE MAX;

EID: 79952994068     PISSN: 14382377     EISSN: 14382385     Source Type: Journal    
DOI: 10.1007/s00217-011-1429-5     Document Type: Article

References (40)

1. Qureshi AA, Burger WC, Peterson DM, Elson CE (1986) The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem 261: 544-550.
2. Packer L (1991) Protective role of vitamin E in biological systems. Am J Clin Nutr 53: 1050S-1055S.
3. Idson B (1993) Vitamins and the skin. Cosm Toilet 108: 79-94.
4. Shirpoor A, Minassian S, Salami S, Khadem-Ansari MH, Ghaderi-Pakdel F, Yeghiazaryan M (2009) Vitamin E protects developing rat hippocampus and cerebellum against ethanol-induced oxidative stress and apoptosis. Food Chem 113: 115-120.
5. Mirvish SS (1986) Effects of vitamins C and E on N-nitroso compound formation, carcinogenesis, and cancer. Cancer 58: 1842-1850.
6. Kato A, Yamoka M, Tanaka A, Komiyama K, Umezewa I (1985) Physiological effect of tocotrienol. Yukagaku 34: 375-376.
7. Tengerdy RP (1980) Effect of vitamin E on immune response. In: Machlin LJ (ed) Vitamin E, a comprehensive treatise. Marcel Dekker, NY, pp 429-444.
8. Liu N, Park HJ (2009) Chitosan-coated nanoliposome as vitamin E carrier. J Microencapsul 26: 235-242.
9. Humberstone AH, Charman WN (1997) Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliver Rev 25: 103-128.
10. Traber MG, Rader D, Acuff RV, Ramakrishnan R, Brewer HB, Kayden HJ (1998) Vitamin E dose-response studies in humans with use of deuterated RRR- alpha-tocopherol. Am J Clin Nutr 68: 847-853.
11. Betz G, Aeppli A, Menshutina N, Leuenberger H (2005) In vivo comparison of various liposome formulations for cosmetic application. Int J Pharm 296: 44-54.
12. Maestrelli F, Gonzalez-Rodryguez ML, Rabasco AM, Mura P (2005) Preparation and characterization of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery. Int J Pharm 298: 55-67.
13. Padamwar MN, Pokharkar VB (2006) Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. Int J Pharm 320: 37-44.
14. Jia-You F, Yann-Lii L, Chia-Chun C, Chia-Hsuan L, Yi-Hung T (2004) Lipid nano/submicron emulsion as vehicle for topical flurbiprofen delivery. Drug Del 11: 97-105.
15. Skalko N, Cajkovac I, Jelsenjak I (1992) Liposome with clindamicyn hydrochloride in the therapy of acne vulgaris. Int J Pharm 85: 97-101.
16. Sharma BB, Jain SK, Vyas SP (1994) Topical liposome system bearing local anasthetic lignocaine: preparation and evaluation. J Microencapsul 11: 279-286.
17. Jdu Plessis, Ramachandran C, Weiner N, Muller DG (1996) The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int J Pharm 127: 273-278.
18. Allen C, Dos Santos N, Gallagher R, Chiu GNC, Shu Y, Li WM, Johnstone SA, Janoff AS, Mayer LD, Webb MS, Bally MB (2002) Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Bioscience Rep 22: 225-250.
19. Vingerhoeds MH, Haisma HJ (1996) Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibodydirected enzyme prodrug therapy (ADEPT): optimization of prodrug activating capacity. Pharm Res 13: 604-610.
20. Janssen APCA, Schiffelers RM, Hagen TLM, Koning GA, Schraa AJ, Kok RJ, Storm G, Molema G (2003) Peptide-targeted PEG-liposomes in anti-angiogenic therapy. Int J Pharm 254: 55-58.
21. Glavas-Dodov M, Fredro-Kumbaradzi E, Goracinova K, Simonoska M, Calis S, Trajkovic-Jolevska S, Hincal AA (2005) The effects of lyophilisation on the stability of liposomes containing 5-FU. Int J Pharm 291: 79-86.
22. Brandl M (2001) Liposomes as drug carriers: a technological approach. Biotechnol Annu Rev 7: 59-85.
23. Glavas-Dodov M, Fredro-Kumbaradzi E, Goracinova K, Calis S, Simonoska M, Hincal AA (2003) 5-Flourouracil in topical liposome gels for anticancer treatment-formulation and eveluation. Acta Pharm 53: 241-250.
24. Verma DD, Verma S, Blume G, Fahr A (2003) Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 258: 141-151.
25. Agrawal V, Paul MK, Mukhopadhyay AK (2005) 6-Mercaptopurine and daunorubicin double drug liposomes preparation, drug-drug interaction and characterization. J Liposome Res 15: 141-155.
26. Takeuchi H, Kojima H, Yamamoto H, Kawashima Y (2000) Polymer coating of liposomes with a modified polyvinyl alcohol and their systemic circulation and RES uptake in rats. J Control Release 68: 195-205.
27. Liu CM, Yang SB, Liu W, Wang RL, Wan J, Liu WL (2010) Preparation and characterization of medium-chain fatty acid liposomes by lyophilization. J Liposome Res 20: 183-190.
28. Gardikis K, Tsimplouli C, Dimas K, Micha-Screttas M, Demetzos C (2010) New chimeric advanced drug delivery nano systems (chi-aDDnSs) as doxorubicin carriers. Int J Pharm 402: 231-237.
29. Fan MH, Xu SY, Xia SQ, Zhang XM (2008) Preparation of salidroside nano-liposomes by ethanol injection method and in vitro release study. Eur Food Res Technol 227: 167-174.
30. Kumar A, Badde S, Kamble R, Pokharkar VB (2010) Development and characterization of liposomal drug delivery system for nimesulide. Int J Pharm Pharm Sci 4: 87-89.
31. Angelini A (2007) Congenital heart disease for the adult cardiologist. Circultion 115: 1296-1305.
32. Hatziantoniou S, Deli G, Nikas Y, Demetzos C, Papaioannou GT (2007) Scanning electron microscopy study on nanoemulsions and solid lipid nanoparticles containing high amounts of ceramides. Micron 38: 819-823.
33. Peng HL, Xiong H, Li JH, Xie MY, Liu YZ, Bai CQ, Chen LX (2010) Vanillin cross-linked chitosan microspheres for controlled release of resveratrol. Food Chem 121: 23-28.
34. Xia SQ, Xu XY (2005) Ferrous sulfate liposomes: preparation, stability and application in fluid milk. Food Res Int 38: 289-296.
35. Yousefi A, Esmaeili F, Rahimian S, Atyabi F, Dinarvand R (2009) Preparation and in vitro evaluation of a pegylated nano-liposomal formulation containing docetaxel. Sci Pharm 77: 453-464.
36. Mu L, Feng SS (2002) Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxols). J Control Rel 80: 129-144.
37. Hinrichs WLJ, Mancenido FA, Sanders NN, Braeckmans K, De Smedt SC, Demeester J, Frijlink HW (2006) The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying. Int J Pharm 311: 237-244.
38. 10 nanoliposomes. J Agric Food Chem 54: 6358-6366.
39. Xu HT, He L, Nie SF, Guan J, Zhang XN, Yang XG, Pan WS (2009) Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits. J Control Release 140: 61-68.
40. Shin J, Shum P, Thompson DH (2003) Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. J Control Release 91: 187-200.